2-Chlorodeoxyadenosine Therapy for Disseminated Langerhans Cell Histiocytosis
Authors:
- Robert L. PhylikyRPRobert L. Phyliky
- Chin-Yang LiCLChin-Yang Li
- Ayalew TefferiATAyalew Tefferi
- 1 March 2003
- journal article
- case report
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 78 (3) , 301-306
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Clinical Outcomes of Pulmonary Langerhans'-Cell Histiocytosis in AdultsNew England Journal of Medicine, 2002
- Nucleoside analogues in the therapy of Langerhans cell histiocytosis: A survey of members of the Histiocyte Society and review of the literatureMedical and Pediatric Oncology, 1999
- Cladribine Activity in Adult Langerhans-Cell HistiocytosisBlood, 1999
- Langerhans cell histiocytosisCancer, 1999
- NOSOLOGY AND PATHOLOGY OF LANGERHANS CELL HISTIOCYTOSISHematology/Oncology Clinics of North America, 1998
- LANGERHANS CELL HISTIOCYTOSIS IN ADULTSHematology/Oncology Clinics of North America, 1998
- CURRENT THERAPY FOR LANGERHANS CELL HISTIOCYTOSISHematology/Oncology Clinics of North America, 1998
- CONTROVERSIES AND NEW APPROACHES TO TREATMENT OF LANGERHANS CELL HISTIOCYTOSISHematology/Oncology Clinics of North America, 1998
- 2-Chlorodeoxyadenosine-Induced Complete Remissions in Langerhans-Cell HistiocytosisAnnals of Internal Medicine, 1994
- 2-Chlorodeoxyadenosine to Treat Refractory Histiocytosis XNew England Journal of Medicine, 1993